No credible reports or official statements have linked the 2026 Andes virus outbreak on the MV Hondius cruise ship to any laboratory incident, driving near-unanimous trader consensus against confirmation by June 30. Investigations by the WHO and CDC trace cases to zoonotic spillover or rare person-to-person transmission, consistent with the virus's established South American rodent reservoir and the index patient's exposure in Argentina. Limited case counts, transparent public health updates, and absence of whistleblower claims or genomic anomalies pointing to lab manipulation reinforce the market's 99.7% implied probability for "No." A realistic upset would require an unprecedented last-minute revelation—such as verified evidence of gain-of-function research or a concealed incident—within the next 12 days, an outcome historical patterns and current data render highly improbable.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedHantavirus lab leak confirmed by June 30?
Hantavirus lab leak confirmed by June 30?
$684,232 Vol.
$684,232 Vol.
Jun 30, 2026
$684,232 Vol.
$684,232 Vol.
Jun 30, 2026
This market will resolve to “Yes” if any hantavirus case linked to the hantavirus outbreak on the MV Hondius cruise ship is confirmed to have originated from a medical laboratory or research facility by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the hantavirus case originated from a medical laboratory, research facility, diagnostic facility, or other controlled laboratory setting is required. Definitive confirmation that the lab-originated case directly caused the outbreak on the MV Hondius is not required, provided a consensus of credible reporting indicates that the lab-originated case is a possible source of, or is otherwise plausibly connected to, the MV Hondius outbreak.
Investigations, speculation, statements that a lab origin is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.No credible reports or official statements have linked the 2026 Andes virus outbreak on the MV Hondius cruise ship to any laboratory incident, driving near-unanimous trader consensus against confirmation by June 30. Investigations by the WHO and CDC trace cases to zoonotic spillover or rare person-to-person transmission, consistent with the virus's established South American rodent reservoir and the index patient's exposure in Argentina. Limited case counts, transparent public health updates, and absence of whistleblower claims or genomic anomalies pointing to lab manipulation reinforce the market's 99.7% implied probability for "No." A realistic upset would require an unprecedented last-minute revelation—such as verified evidence of gain-of-function research or a concealed incident—within the next 12 days, an outcome historical patterns and current data render highly improbable.
This market will resolve to “Yes” if any hantavirus case linked to the hantavirus outbreak on the MV Hondius cruise ship is confirmed to have originated from a medical laboratory or research facility by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the hantavirus case originated from a medical laboratory, research facility, diagnostic facility, or other controlled laboratory setting is required. Definitive confirmation that the lab-originated case directly caused the outbreak on the MV Hondius is not required, provided a consensus of credible reporting indicates that the lab-originated case is a possible source of, or is otherwise plausibly connected to, the MV Hondius outbreak.
Investigations, speculation, statements that a lab origin is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the hantavirus case originated from a medical laboratory, research facility, diagnostic facility, or other controlled laboratory setting is required. Definitive confirmation that the lab-originated case directly caused the outbreak on the MV Hondius is not required, provided a consensus of credible reporting indicates that the lab-originated case is a possible source of, or is otherwise plausibly connected to, the MV Hondius outbreak.
Investigations, speculation, statements that a lab origin is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Market Opened: May 7, 2026, 1:43 PM ET
Volume
$684,232End Date
Jun 30, 2026Market Opened
May 7, 2026, 1:43 PM ETResolver
0x65070BE91...Outcome proposed: No
No dispute
Final outcome: No
This market will resolve to “Yes” if any hantavirus case linked to the hantavirus outbreak on the MV Hondius cruise ship is confirmed to have originated from a medical laboratory or research facility by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the hantavirus case originated from a medical laboratory, research facility, diagnostic facility, or other controlled laboratory setting is required. Definitive confirmation that the lab-originated case directly caused the outbreak on the MV Hondius is not required, provided a consensus of credible reporting indicates that the lab-originated case is a possible source of, or is otherwise plausibly connected to, the MV Hondius outbreak.
Investigations, speculation, statements that a lab origin is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.No credible reports or official statements have linked the 2026 Andes virus outbreak on the MV Hondius cruise ship to any laboratory incident, driving near-unanimous trader consensus against confirmation by June 30. Investigations by the WHO and CDC trace cases to zoonotic spillover or rare person-to-person transmission, consistent with the virus's established South American rodent reservoir and the index patient's exposure in Argentina. Limited case counts, transparent public health updates, and absence of whistleblower claims or genomic anomalies pointing to lab manipulation reinforce the market's 99.7% implied probability for "No." A realistic upset would require an unprecedented last-minute revelation—such as verified evidence of gain-of-function research or a concealed incident—within the next 12 days, an outcome historical patterns and current data render highly improbable.
This market will resolve to “Yes” if any hantavirus case linked to the hantavirus outbreak on the MV Hondius cruise ship is confirmed to have originated from a medical laboratory or research facility by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the hantavirus case originated from a medical laboratory, research facility, diagnostic facility, or other controlled laboratory setting is required. Definitive confirmation that the lab-originated case directly caused the outbreak on the MV Hondius is not required, provided a consensus of credible reporting indicates that the lab-originated case is a possible source of, or is otherwise plausibly connected to, the MV Hondius outbreak.
Investigations, speculation, statements that a lab origin is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the hantavirus case originated from a medical laboratory, research facility, diagnostic facility, or other controlled laboratory setting is required. Definitive confirmation that the lab-originated case directly caused the outbreak on the MV Hondius is not required, provided a consensus of credible reporting indicates that the lab-originated case is a possible source of, or is otherwise plausibly connected to, the MV Hondius outbreak.
Investigations, speculation, statements that a lab origin is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Volume
$684,232End Date
Jun 30, 2026Market Opened
May 7, 2026, 1:43 PM ETResolver
0x65070BE91...Outcome proposed: No
No dispute
Final outcome: No
No credible reports or official statements have linked the 2026 Andes virus outbreak on the MV Hondius cruise ship to any laboratory incident, driving near-unanimous trader consensus against confirmation by June 30. Investigations by the WHO and CDC trace cases to zoonotic spillover or rare person-to-person transmission, consistent with the virus's established South American rodent reservoir and the index patient's exposure in Argentina. Limited case counts, transparent public health updates, and absence of whistleblower claims or genomic anomalies pointing to lab manipulation reinforce the market's 99.7% implied probability for "No." A realistic upset would require an unprecedented last-minute revelation—such as verified evidence of gain-of-function research or a concealed incident—within the next 12 days, an outcome historical patterns and current data render highly improbable.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions